{"name": "Galenea",
 "permalink": "galenea",
 "crunchbase_url": "http://www.crunchbase.com/company/galenea",
 "homepage_url": "http://www.galenea.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2004,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@Galenea.com",
 "phone_number": "(617) 374-1010",
 "description": "",
 "created_at": "Thu Jul 28 03:32:12 UTC 2011",
 "updated_at": "Fri Mar 29 07:58:06 UTC 2013",
 "overview": "\u003Cp\u003EGalenea Corp., a biopharmaceutical company, engages in developing therapeutics for central nervous system (CNS) diseases. The company focuses on psychiatric disorders, schizophrenia and calcineurin, and obesity and 5-HT2C agonists. Its products include in vitro and in vivo synaptic functional screening and brain slice electrophysiology assays, which include techniques for recording disease-relevant neuronal activity in the prefrontal cortex to measure the effects of drug candidates in animals performing critical memory or cognition-dependent tasks. The company was founded in 2003 and is based in Cambridge, Massachusetts.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       22],
      "assets/images/resized/0014/6615/146615v1-max-150x150.png"],
     [[250,
       37],
      "assets/images/resized/0014/6615/146615v1-max-250x250.png"],
     [[321,
       48],
      "assets/images/resized/0014/6615/146615v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Mark",
      "last_name": "B. Benjamin",
      "permalink": "mark-b-benjamin",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "David",
      "last_name": "Neafus",
      "permalink": "david-neafus",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "David",
      "last_name": "Neafus",
      "permalink": "david-neafus-2",
      "image":
       {"available_sizes":
         [[[118,
            118],
           "assets/images/resized/0027/1865/271865v1-max-150x150.png"],
          [[118,
            118],
           "assets/images/resized/0027/1865/271865v1-max-250x250.png"],
          [[118,
            118],
           "assets/images/resized/0027/1865/271865v1-max-450x450.png"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$13.5M",
 "funding_rounds":
  [{"round_code": "grant",
    "source_url": "http://www.galenea.com/story.php?id=10",
    "source_description": "Galenea Awarded $4.5 Million Grant for Advancement of Innovative Synaptic Transmission Screen",
    "raised_amount": 4500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 14,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2012/04/galenea-receives-6m-equity-investment-stanley-medical-research-institute.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Galenea Receives $6M Equity Investment from The Stanley Medical Research Institute",
    "raised_amount": 6000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 4,
    "funded_day": 26,
    "investments":
     []},
   {"round_code": "grant",
    "source_url": "http://in.finance.yahoo.com/news/galenea-awarded-3-million-nih-160000592.html",
    "source_description": "Galenea Awarded $3 Million NIH Grant to Develop Translational EEG Biomarkers for Schizophrenia",
    "raised_amount": 3000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 9,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "National Institutes of Health",
         "permalink": "national-institutes-of-health",
         "image":
          {"available_sizes":
            [[[150,
               23],
              "assets/images/resized/0025/4340/254340v1-max-150x150.png"],
             [[250,
               38],
              "assets/images/resized/0025/4340/254340v1-max-250x250.png"],
             [[391,
               60],
              "assets/images/resized/0025/4340/254340v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "300 Technology Square",
    "address2": "2nd Floor ",
    "zip_code": "02139",
    "city": "Cambridge",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}